Chemotherapy of myosarcoma (leio- and rhabdomyosarcoma).
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D007890:Leiomyosarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use; D009217:Myosarcoma / Q000000981:diagnostic imaging; D011379:Prognosis; D011859:Radiography; D012208:Rhabdomyosarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002699:Chlorambucil; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate; D003630:Daunorubicin